vs

Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and TREACE MEDICAL CONCEPTS, INC. (TMCI). Click either name above to swap in a different company.

TREACE MEDICAL CONCEPTS, INC. is the larger business by last-quarter revenue ($62.5M vs $47.3M, roughly 1.3× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -15.0%, a 16.2% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs -9.0%). Mama's Creations, Inc. produced more free cash flow last quarter ($3.7M vs $-10.4M). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs 10.6%).

Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

MAMA vs TMCI — Head-to-Head

Bigger by revenue
TMCI
TMCI
1.3× larger
TMCI
$62.5M
$47.3M
MAMA
Growing faster (revenue YoY)
MAMA
MAMA
+59.0% gap
MAMA
50.0%
-9.0%
TMCI
Higher net margin
MAMA
MAMA
16.2% more per $
MAMA
1.1%
-15.0%
TMCI
More free cash flow
MAMA
MAMA
$14.1M more FCF
MAMA
$3.7M
$-10.4M
TMCI
Faster 2-yr revenue CAGR
MAMA
MAMA
Annualised
MAMA
33.0%
10.6%
TMCI

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
MAMA
MAMA
TMCI
TMCI
Revenue
$47.3M
$62.5M
Net Profit
$540.0K
$-9.4M
Gross Margin
23.6%
80.6%
Operating Margin
1.7%
-9.5%
Net Margin
1.1%
-15.0%
Revenue YoY
50.0%
-9.0%
Net Profit YoY
31.7%
-1775.0%
EPS (diluted)
$0.01
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MAMA
MAMA
TMCI
TMCI
Q4 25
$47.3M
$62.5M
Q3 25
$35.2M
$50.2M
Q2 25
$35.3M
$47.4M
Q1 25
$33.6M
$52.6M
Q4 24
$31.5M
$68.7M
Q3 24
$28.4M
$45.1M
Q2 24
$29.8M
$44.5M
Q1 24
$26.7M
$51.1M
Net Profit
MAMA
MAMA
TMCI
TMCI
Q4 25
$540.0K
$-9.4M
Q3 25
$1.3M
$-16.3M
Q2 25
$1.2M
$-17.4M
Q1 25
$1.6M
$-15.9M
Q4 24
$410.0K
$-501.0K
Q3 24
$1.1M
$-15.4M
Q2 24
$553.0K
$-21.2M
Q1 24
$1.4M
$-18.7M
Gross Margin
MAMA
MAMA
TMCI
TMCI
Q4 25
23.6%
80.6%
Q3 25
24.9%
79.1%
Q2 25
26.1%
79.7%
Q1 25
27.0%
79.7%
Q4 24
22.6%
80.7%
Q3 24
24.2%
80.1%
Q2 24
25.0%
80.2%
Q1 24
29.3%
80.2%
Operating Margin
MAMA
MAMA
TMCI
TMCI
Q4 25
1.7%
-9.5%
Q3 25
4.8%
-31.2%
Q2 25
4.5%
-35.8%
Q1 25
5.7%
-29.6%
Q4 24
1.8%
-0.3%
Q3 24
5.7%
-33.6%
Q2 24
2.6%
-48.1%
Q1 24
7.4%
-37.1%
Net Margin
MAMA
MAMA
TMCI
TMCI
Q4 25
1.1%
-15.0%
Q3 25
3.6%
-32.4%
Q2 25
3.5%
-36.7%
Q1 25
4.8%
-30.3%
Q4 24
1.3%
-0.7%
Q3 24
4.0%
-34.1%
Q2 24
1.9%
-47.7%
Q1 24
5.3%
-36.5%
EPS (diluted)
MAMA
MAMA
TMCI
TMCI
Q4 25
$0.01
$-0.14
Q3 25
$0.03
$-0.26
Q2 25
$0.03
$-0.28
Q1 25
$0.04
$-0.25
Q4 24
$0.01
$-0.01
Q3 24
$0.03
$-0.25
Q2 24
$0.01
$-0.34
Q1 24
$0.03
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MAMA
MAMA
TMCI
TMCI
Cash + ST InvestmentsLiquidity on hand
$18.1M
$48.4M
Total DebtLower is stronger
$55.6M
Stockholders' EquityBook value
$49.6M
$87.3M
Total Assets
$84.0M
$190.6M
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MAMA
MAMA
TMCI
TMCI
Q4 25
$18.1M
$48.4M
Q3 25
$9.4M
$57.4M
Q2 25
$12.0M
$69.3M
Q1 25
$7.2M
$76.1M
Q4 24
$9.3M
$75.7M
Q3 24
$7.4M
$82.8M
Q2 24
$13.0M
$95.0M
Q1 24
$11.0M
$110.0M
Total Debt
MAMA
MAMA
TMCI
TMCI
Q4 25
$55.6M
Q3 25
$53.5M
Q2 25
$53.5M
Q1 25
$53.4M
Q4 24
$53.3M
Q3 24
$53.2M
Q2 24
$53.2M
Q1 24
$53.1M
Stockholders' Equity
MAMA
MAMA
TMCI
TMCI
Q4 25
$49.6M
$87.3M
Q3 25
$29.6M
$89.2M
Q2 25
$26.4M
$97.6M
Q1 25
$24.9M
$105.3M
Q4 24
$23.0M
$112.9M
Q3 24
$22.3M
$104.9M
Q2 24
$20.3M
$112.1M
Q1 24
$19.6M
$126.4M
Total Assets
MAMA
MAMA
TMCI
TMCI
Q4 25
$84.0M
$190.6M
Q3 25
$51.2M
$196.6M
Q2 25
$52.7M
$206.4M
Q1 25
$47.1M
$205.8M
Q4 24
$47.9M
$217.1M
Q3 24
$43.0M
$212.9M
Q2 24
$47.2M
$226.1M
Q1 24
$45.1M
$242.7M
Debt / Equity
MAMA
MAMA
TMCI
TMCI
Q4 25
0.64×
Q3 25
0.60×
Q2 25
0.55×
Q1 25
0.51×
Q4 24
0.47×
Q3 24
0.51×
Q2 24
0.47×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MAMA
MAMA
TMCI
TMCI
Operating Cash FlowLast quarter
$3.9M
$-8.0M
Free Cash FlowOCF − Capex
$3.7M
$-10.4M
FCF MarginFCF / Revenue
7.8%
-16.7%
Capex IntensityCapex / Revenue
0.4%
3.8%
Cash ConversionOCF / Net Profit
7.16×
TTM Free Cash FlowTrailing 4 quarters
$6.0M
$-29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MAMA
MAMA
TMCI
TMCI
Q4 25
$3.9M
$-8.0M
Q3 25
$-1.7M
$-9.1M
Q2 25
$6.0M
$-3.0M
Q1 25
$-857.0K
$4.2M
Q4 24
$4.8M
$-4.2M
Q3 24
$-2.4M
$-11.8M
Q2 24
$3.6M
$-13.9M
Q1 24
$6.7M
$-7.2M
Free Cash Flow
MAMA
MAMA
TMCI
TMCI
Q4 25
$3.7M
$-10.4M
Q3 25
$-2.2M
$-11.9M
Q2 25
$5.5M
$-7.8M
Q1 25
$-930.0K
$655.0K
Q4 24
$2.5M
$-7.3M
Q3 24
$-4.0M
$-14.7M
Q2 24
$2.5M
$-15.6M
Q1 24
$6.6M
$-11.1M
FCF Margin
MAMA
MAMA
TMCI
TMCI
Q4 25
7.8%
-16.7%
Q3 25
-6.2%
-23.7%
Q2 25
15.5%
-16.5%
Q1 25
-2.8%
1.2%
Q4 24
8.0%
-10.6%
Q3 24
-14.1%
-32.6%
Q2 24
8.4%
-35.2%
Q1 24
24.8%
-21.8%
Capex Intensity
MAMA
MAMA
TMCI
TMCI
Q4 25
0.4%
3.8%
Q3 25
1.5%
5.6%
Q2 25
1.5%
10.1%
Q1 25
0.2%
6.7%
Q4 24
7.2%
4.5%
Q3 24
5.6%
6.4%
Q2 24
3.8%
3.9%
Q1 24
0.4%
7.7%
Cash Conversion
MAMA
MAMA
TMCI
TMCI
Q4 25
7.16×
Q3 25
-1.31×
Q2 25
4.85×
Q1 25
-0.54×
Q4 24
11.71×
Q3 24
-2.10×
Q2 24
6.58×
Q1 24
4.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons